Fingerprint
Dive into the research topics of 'First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically